Inosine -a naturally occurring purine-was long considered to be 
INTRODUCTION
It is well known that certain naturally occurring purines can exert a powerful modulatory effects on the immune system. The nucleoside adenosine is the best characterized of these purines and has been shown to affect almost all aspects of an immune response (1-3) . Adenosine and its analogs can affect the development of a variety of inflammatory diseases including endotoxic shock (4) , rheumatoid arthritis (5) , pleural inflammation (6) , nephritis (7) , uveitis (8) , and colitis (9) . Adenosine's effects are partly mediated by the inhibition of deleterious immune-mediated processes, including the release of pro-inflammatory cytokines and free radicals (10) . Inosine is a naturally occurring purine, formed from the breakdown of adenosine by adenosine deaminase (11) . Although inosine was widely believed to be inert, it had been demonstrated that inosine inhibits the release of pro-inflammatory cytokines and chemokines by activated murine macrophages (12) , and that such compound exerts a powerful -in vivoanti-inflammatory effects in murine endotoxic shock (12, 13) , colitis (9) , septic shock (14) , and severe lung inflammation (15) . Inosine also has antiinflammatory effects on human cells in vitro, reducing tumor necrosis factor-α (TNF-α) and interleukin (IL)-1β production by monocytes and epithelial cells in response to lipopolysaccharide treatment, as well as inhibiting super oxide radical production by activated human neutrophils (16 
MATERIALS & METHODS

Materials
Reagents were obtained from the following sources. Streptozotocin and sodium citrate were obtained from Sigma (St. Louis, MO, USA). Insulin was measured by immunometric assay according to the protocol of Immulite (Diagnostic Product Corporation, U.S.A) using Immulite Automated Immunoassay Analyzer (Diagnostic Product Corporation, U.S.A) which automates the entire assay process.
Animals
The current work was done on 50 male mice, weighing 150-250 g and average 12 weeks old .They were classified into 5 groups, 10 mice in each group. Group 1 (control group), were given water orally (Vehicle) starting on day one. Group II was given inosine alone. Group III was treated with streptozotocin (40 mg/kg dissolved in citrate buffer, pH 4.5) intraperitoneally for 5 consecutive days. Groups IV and V were treated as group III and at the same time were treated every day starting on day one with inosine 100 and 200 mg/ kg/day respectively.
Blood glucose was measured on days 1, 7, 14, and 21. Hyperglycemia was defined as a non fasting blood glucose level ≥ 140 mg/dl. Determination of Pancreatic Insulin and Malondialdehyde.
Insulin contents in pancreas of mice were determined from a pancreas biopsy, which was homogenized in acidified ethanol (75% ethanol, 1.5% 12 mol/L HCl, and 23.5% H 2 O), and then incubated for 72 h at 4 °C and centrifuged. Care was taken to remove biopsies from the same location of the pancreas (body) to avoid differences between the regions of the pancreas in regards to insulin content. The insulin content of the supernatant was determined using immulite insulin kit (Diagnostic Product Corporation, U.S.A). Pancreatic insulin content was expressed as ng insulin/mg protein, which was determined by the Bradford assay (26) . Malondialdehyde (MDA) content was determined from a pancreatic biopsy homogenized in 1.15% KCl buffer. Homogenate (200 µL) was added to a reaction mixture consisting of 1.5 ml 0.8% thiobarbituric acid, 200 µL 8.1% sodium dodecyl sulfate, 1.5 ml 20% acetic acid (pH 3.5), and 600 µL distilledH2O. The mixture was incubated at 90 °C for 45 min. After cooling to room temperature, the sample was cleared by centrifugation (10000 × g, 10 min) and absorbance was measured at 532 nm, using 1,1,3,3-tetra-methoxypropane as an external standard (14). Results were expressed as pmol MDA/mg protein.
Statistical Analyses
Data were presented as means ± SD. Statistical analysis was performed using the t-test as appropriate; P < 0.05 was considered significant. Table 1 and Figure 1 showed that MLDS treatment induced a progressive hyperglycemia over a 21-day period (blood glucose ≥ 140 mg /dL) in mice. Inosine at 100 and 200 mg /kg/day significantly reduced the rise in mean blood glucose level at 21 day from 209.4±11.78 to 156.85±9.1(P < 0.001) & and 127.6±9.3 (P< 0.001) respectively. Inosine alone had no effect on blood glucose (60.9±7.8). all suppress the production of inflammatory mediators without affecting transcriptional events. The post-transcriptional nature of inosine's mechanism of action would be preferable to transcriptional inhibitors, because it would be expected to increase the window of therapeutic opportunity, and may remain effective even in a posttreatment paradigm.
RESULTS
Other data has, also, indicated that inosine at millimolar concentrations in vitro can inhibit the enzyme, poly (ADP-ribose) polymerase (42) , an enzyme implicated in the pathogenesis of various forms of inflammation including autoimmune diabetes (23,43) . We do not know whether the concentrations of inosine achieved in this study in vivo reached levels at which a significant inhibition of poly (ADP-ribose) polymerase could have accounted for the protective effects of inosine against diabetes. Inosine has been shown to be more than just an "inactive" metabolite of adenosine, acting not only as an anti-inflammatory agent (9,12-16) , but also, preventing glial cell death during glucose deprivation (44) , decreasing the release of intracellular enzymes from hypoxic lymphocytes (45) , improving renal function during ischemia (46) , and removing the harmful effects of total hepatic ischemia (47) . Inosine, also, reduced the severity of acute pancreatitis, suggesting a possible application of that compound in the treatment of acute pancreatitis (48) and protecting against allergic encephalomyelitis (49) . As described above, the mechanism through which inosine exerts its anti-inflammatory effect is still unclear, and likely to employ multiple mechanisms. An additional mechanism, recently highlighted by studies in murine encephalomyelitis models, may be related to direct antioxidant effects: inosine is broken down in vivo to produce uric acid, and uric acid has potent antioxidant properties against peroxynitrite and other reactive oxygen species (49) . Therefore, at least some of the therapeutic effects, particularly on the inflammatory processes and possibly islet cell damage could be mediated by the antioxidant action of uric acid. In fact, the protective effects of uric acid in a variety of models of 
